You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 2, 2025

~ Buy the ALVESCO (ciclesonide) Drug Profile, 2024 PDF Report in the Report Store ~

Drug Price Trends for ALVESCO


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ALVESCO

Average Pharmacy Cost for ALVESCO

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ALVESCO 160 MCG INHALER 70515-0712-01 43.09848 GM 2024-12-18
ALVESCO 80 MCG INHALER 70515-0711-01 43.13207 GM 2024-12-18
ALVESCO 80 MCG INHALER 70515-0711-01 43.12951 GM 2024-11-20
ALVESCO 160 MCG INHALER 70515-0712-01 43.11620 GM 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

ALVESCO Market Analysis and Financial Projection

Market Analysis and Price Projections for ALVESCO (Ciclesonide)

Introduction to ALVESCO

ALVESCO (ciclesonide) is an inhaled corticosteroid used for the maintenance treatment and prophylactic therapy of asthma in adult and adolescent patients aged 12 years and older. It is characterized by its novel release and distribution properties, making it a unique treatment option in the asthma medication market[1].

Market Size and Growth

The global asthma drugs market, which includes medications like ALVESCO, is projected to grow significantly. According to a report by The Insight Partners, the global asthma drugs market is expected to reach USD 34.13 billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 5.0% from 2021 to 2028. This growth is driven by increasing demand for effective asthma treatments and advancements in medication delivery systems[4].

Competitive Landscape

ALVESCO operates within a competitive landscape dominated by various asthma medications. However, its unique mechanism of action, where ciclesonide is activated by intracellular esterases following oral inhalation, sets it apart. This prodrug characteristic allows for targeted action against multiple inflammatory cell types and chemicals involved in the asthmatic response, making it a valuable option for patients[1].

Pricing and Cost Factors

The cost of ALVESCO can vary based on several factors, including the pharmacy, insurance coverage, and treatment plan.

  • Retail Price: The cost for ALVESCO (80 mcg/inh or 160 mcg/inh) inhalation aerosol is approximately $298 for a supply of 6.1 grams, depending on the pharmacy[2][3].
  • Wholesaler Acquisition Costs (WAC): For Colorado prescribers, the WAC for ALVESCO inhalation aerosol is listed at $274.21 for both the 80 mcg and 160 mcg strengths[3].
  • Insurance and Savings Programs: The final cost to the patient can be significantly influenced by insurance coverage and savings programs. For example, using coupons or obtaining a 90-day supply can help reduce costs[5].

Financial and Insurance Assistance

Given that ALVESCO is only available as a brand-name drug and does not have a generic version, it can be more expensive than generic alternatives. However, several financial assistance options are available:

  • Savings Programs: Manufacturers and third-party providers often offer savings programs, such as coupons and copay cards, to help reduce the out-of-pocket cost for patients[5].
  • Insurance Coverage: Patients with insurance may have lower copays or coinsurance rates, depending on their insurance plan[5].

Generic Availability

As of now, ALVESCO does not have a generic version available. This is due to its patent protection, which allows the manufacturer to maintain exclusive rights to the drug until the patent expires. The lack of generic competition contributes to the higher cost of the brand-name drug[5].

Market Projections and Trends

The asthma drugs market, including ALVESCO, is expected to continue growing due to several factors:

  • Increasing Prevalence of Asthma: The rising prevalence of asthma globally drives the demand for effective treatments.
  • Advancements in Medication Delivery: Innovations in inhalation technologies and drug formulations are expected to enhance patient compliance and treatment outcomes.
  • Regulatory Environment: Changes in regulatory policies, such as those in Colorado requiring the disclosure of Wholesaler Acquisition Costs, can impact pricing transparency and market dynamics[4].

Regional Market Analysis

The global asthma drugs market is segmented into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Each region has its own market dynamics, influenced by local healthcare policies, insurance coverage, and patient demographics. For instance, the U.S. market, where ALVESCO is approved, is one of the largest pharmaceutical markets globally, offering significant opportunities for growth[4].

Key Takeaways

  • Market Growth: The asthma drugs market, including ALVESCO, is projected to grow at a CAGR of 5.0% from 2021 to 2028.
  • Pricing: The cost of ALVESCO varies but is generally around $298 for a 6.1-gram supply, with potential savings through insurance and savings programs.
  • Competitive Advantage: ALVESCO’s unique mechanism of action sets it apart in the market.
  • Generic Availability: No generic version is currently available due to patent protection.
  • Financial Assistance: Various savings programs and insurance options can help reduce the cost for patients.

FAQs

1. What is ALVESCO used for? ALVESCO (ciclesonide) is used for the maintenance treatment and prophylactic therapy of asthma in adult and adolescent patients aged 12 years and older[1].

2. How much does ALVESCO cost? The cost of ALVESCO is approximately $298 for a supply of 6.1 grams, depending on the pharmacy and other factors such as insurance coverage[2][3].

3. Is there a generic version of ALVESCO available? No, there is no generic version of ALVESCO available as it is still under patent protection[5].

4. What are the key factors affecting the cost of ALVESCO? The cost of ALVESCO can be influenced by factors such as the pharmacy, insurance coverage, treatment plan, and availability of savings programs[5].

5. How can patients save money on ALVESCO prescriptions? Patients can save money by using coupons, copay cards, and potentially obtaining a 90-day supply if approved by their insurance provider[5].

Sources

  1. Nycomed's ALVESCO(R) Gains FDA Approval for the U.S. Market - Biospace
  2. Alvesco Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
  3. Alvesco WAC | Covis Pharma - Covis Pharma
  4. Asthma Drugs Market (Medications, Route of Administration) Reach ... - The Insight Partners
  5. Alvesco cost 2024: Coupons and more - MedicalNewsToday

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.